Compare Davita Inc (DVA) vs General Mills, Inc. (GIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs General Mills, Inc. — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while General Mills, Inc. trades at $37.83 (market cap $19.89B). The key difference: General Mills, Inc. is the larger of the two by market cap, and General Mills, Inc. pays a 6.55% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | GIS | |
|---|---|---|
Market Cap | $11.72B | $19.89B |
Sector | Health | Consumer Staples |
52-Week High | $240.96 | $51.11 |
52-Week Low | $103.87 | $32.17 |
Enterprise Value | $24.44B | $33.37B |
Dividend Yield | — | 6.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
General Mills (GIS) trades at $36.89, up 2.27% today, with a bullish technical signal from moving averages. The stock shows mixed fundamentals with declining revenue ($19.49B in 2025) and negative net income margin (-0.48%), though it beat Q2 2026 EPS estimates. Valuation appears attractive with P/E of 9.23 and P/S of 1.08. Recent news highlights cost-saving initiatives and new product launches, while analyst consensus remains cautious with 61% hold ratings.
Outlook: GIS faces headwinds from soft consumer demand and margin pressure, but its cost-saving strategy and dividend yield offer some stability. Risks include competitive threats and high debt levels. The stock presents a value opportunity for income-focused investors if management can execute its turnaround plan effectively.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →
